SEC Tracker
Get the app

Apogee Therapeutics APGE

Apogee Therapeutics: ends a material agreement, completes an acquisition or sale of assets and 5 other items

Form
8-K
Filed
Importance
Routine
  • Ends a material agreement (1.02)
  • Completes an acquisition or sale of assets (2.01)
  • Reports an exchange listing deficiency notice (3.01)
  • Changes shareholder rights (3.03)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Amends its charter or bylaws (5.03)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Apogee Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Amicus Therapeutics FOLD public float $1.7B, Jun 30, 2025
  2. Apellis Pharmaceuticals APLS public float $1.8B, Jun 30, 2025
  3. Supernus Pharmaceuticals SUPN public float $1.7B, Jun 30, 2025
  4. Indivior Pharmaceuticals INDV public float $1.8B, Jun 30, 2025
  5. Sarepta Therapeutics SRPT public float $1.7B, Jun 30, 2025